
Watch Dr. Devika Das, from University of Alabama at Birmingham Medicine, discuss the benefits of telemedicine in cancer care during the CURE® Educated Patient® Lung Cancer Summit.

Sailaja Darisipudi(she/her) has previously led communications for nonprofit organizations fighting against gendered violence and worked as an educator. She believes passionately in fighting for gender equality, destigmatizing mental health, making quality health resources available across socio-economic statuses and decreasing the gap between public education and the complexities of the American health care system. At Rutgers University, Sailaja studied public health, wrote and edited for newspapers such as RU Examiner and EMSOP Chronicles and accumulated an alarming number of parking tickets. When not working, Sailaja can be found getting lost (literally and metaphorically) in new cities, overanalyzing various romance books and streaming shows and ordering all the vegetarian items at different restaurants. You can also find her on Twitter at @SailajaDee.

Watch Dr. Devika Das, from University of Alabama at Birmingham Medicine, discuss the benefits of telemedicine in cancer care during the CURE® Educated Patient® Lung Cancer Summit.

A man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.

A woman with stage 2 invasive ductal carcinoma — a type of breast cancer that begins in the milk ducts of the breast — shares how her experience as an employee at a breast cancer research facility helped her push against doctors who minimized her ultrasound findings and how her Ki-67 score informed her treatment choices.

CURE® surveyed its audience to gather insight into what unexpected lessons cancer has taught them. Here’s what they had to say.

A patient with metastatic breast cancer shares how she learned that her disease was recently reclassified as HER-2 low, and what it was like to first learn about the FDA-approved drug years before she would be prescribed the treatment.

CURE® surveyed its audience to see how cancer-related pain or treatment-related side effects interfered with their ability to be independent. Here’s what they had to say.

Ten years after being diagnosed with cancer, 11-year-old, 3-time neuroblastoma survivor Micah Bernstein and her father, Jeff, discuss how childhood cancer has changed over the past decade.

Seven years after completing breast cancer treatment, Angelia Carpenter was shocked to discover she had angiosarcoma, a rare cancer that may have been associated with her breast cancer treatment.

CURE® surveyed its audience to see how their cancer diagnosis affected their mental health. Here’s what they had to say.

In honor of Childhood Cancer Awareness Month in September, CURE® compiled a roundup of some of the top stories involving the latest updates in the pediatric cancer space that patients and their families may have missed.

CURE® surveyed its audience to see what good habits they have picked up since being diagnosed with cancer. Here’s what they had to say.

Cervical cancer survivor Ginny Marable heard about a story of a fellow cervical cancer survivor, Tamika Felder, not being able to preserve her fertility. The story moved Marable so much that she and her husband donated their embryos to Felder.

The death of “Grease” star Olivia Newton-John from metastatic breast cancer has triggered discussions about the specifics of the disease. Here, CURE® details what metastatic breast cancer is.

A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.

Watch Dr. Edward S. Kim, from City of Hope, discuss targeted therapy during the CURE Educated Patient Lung Cancer Summit.

Watch Elisabeth King, from City of Hope, discuss biomarker testing during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Anna C. Pavlick, from Weill Cornell Medicine, discuss clinical trials during the CURE Educated Patient Skin Cancer Summit.

Treatment with Gen-1, a novel gene therapy, resulted in a 33% improvement in progression-free survival for patients with advanced ovarian cancer, according to recent study findings.

Culturally specific resources are needed to help fight against the stigmas Asian American cancer survivors and patients face, according to a group of experts.

In less than a year, Christine Whelchel went from receiving a diagnosis of breast cancer to becoming a trailblazing “Jeopardy!” champion.

Findings from several studies have shown that childhood cancer survivors often stop attending much needed follow-up visits in the years following treatment.

Adolescents and young adults with sarcoma, a group of cancers that begin in the bone and soft tissue, need more education regarding chronic pain management and opioid addiction, according to a group of researchers.